Analysis Group Health Care Consultants Present at ISPOR 2019
Dates: May 18–22, 2019
Host:International Society for Pharmacoeconomics and Outcomes Research (ISPOR)
Location:New Orleans, LA
Members of Analysis Group's Health Care practice will lead and participate in an educational symposium, make a podium presentation, and present 19 research posters at ISPOR 2019 in New Orleans. In addition, one of our experts will moderate a breakout session for a podium presentation.
Vice President Michael Kuehn will moderate the symposium “Cell and Gene Therapy – Value and Access,” which will also include Analysis Group Managing Principal Eric Q. Wu and Vice President Hongbo Yang. The symposium will aim to introduce attendees to common considerations when valuing and pricing cell and gene therapies, as well as those concerning reimbursement access.
Vice President Jenny Zhou will make a podium presentation on “Assessing the Relationship Between Lifelong Value and Pricing for Orphan Drugs in Ultra-Rare Diseases.” Managing Principal Mei Sheng Duh will moderate a breakout session for a podium presentation on conceptual papers.
The 19 poster sessions will include two research presentation award finalists: “Is Increased Severity Status Associated with Incremental Economic Burden in Privately Insured US Patients with Treatment Resistant Depression?” and “Rapid Initiation of Antiretroviral Treatment (ART) Following Diagnosis of Human Immunodeficiency Virus (HIV) Among Medicaid Beneficiaries: A Real-World Evaluation.”
A complete list of our presentations and posters is available here.